Public trial registry of the CCC-Munich

Trial KRT-232-101 (BOREAS)

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
KRT-232-101 (BOREAS)
World
Full title
:

An Open-Label, Phase 2a/2b Study of KRT-232 in Subjects With Primary Myelofibrosis (PMF), Post–Polycythemia Vera MF (Post–PV-MF), Or Post–Essential Thrombocythemia MF (Post– ET-MF) Who Have Failed Prior Treatment with a JAK Inhibitor

World
NCT number
:
World
Responsible organization
:
3. Med 3. Med Ismaninger Str. 22 81675 München Germany
Indications
Classification Code Description
- - Other trials
Trial design
World
Phase
:
II
Status
World
Status
:
Recruitment finished
Votes
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Therapy
World
Therapy
:

Zielgerichtet

Participants
Function Prename Surname Organization
World Responsible contact Peter Herhaus 3. Med 3. Med Ismaninger Str. 22 81675 München Germany Magnifier